These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 33170349
1. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Chatzantonis G, Bietenbeck M, Elsanhoury A, Tschöpe C, Pieske B, Tauscher G, Vietheer J, Shomanova Z, Mahrholdt H, Rolf A, Kelle S, Yilmaz A. Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349 [Abstract] [Full Text] [Related]
3. Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging. Chamling B, Drakos S, Bietenbeck M, Klingel K, Meier C, Yilmaz A. Front Cardiovasc Med; 2021 Apr; 8():757642. PubMed ID: 34646875 [Abstract] [Full Text] [Related]
4. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Slivnick JA, Alvi N, Singulane CC, Scheetz S, Goyal A, Patel H, Sarswat N, Addetia K, Fernandes F, Vieira MLC, Cafezeiro CRF, Carvalhal SF, Simonetti OP, Singh J, Lang RM, Zareba KM, Patel AR. Eur Heart J Cardiovasc Imaging; 2023 May 31; 24(6):829-837. PubMed ID: 36624559 [Abstract] [Full Text] [Related]
5. Magnetic Resonance in Transthyretin Cardiac Amyloidosis. Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T, Rosmini S, Quarta CC, Whelan CJ, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M. J Am Coll Cardiol; 2017 Jul 25; 70(4):466-477. PubMed ID: 28728692 [Abstract] [Full Text] [Related]
6. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients. Yue X, Yang L, Wang R, Chan Q, Yang Y, Wu X, Ruan X, Zhang Z, Wei Y, Wang F. Front Cardiovasc Med; 2022 Jul 25; 9():1017097. PubMed ID: 36330005 [Abstract] [Full Text] [Related]
8. Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation. Gil KE, Truong V, Liu C, Ibrahim DY, Mikrut K, Satoskar A, Varghese J, Kahwash R, Han Y. Int J Cardiovasc Imaging; 2024 Dec 25; 40(12):2559-2570. PubMed ID: 39417970 [Abstract] [Full Text] [Related]
9. Cardiac amyloidosis: in search of the ideal diagnostic tool. Mavrogeni SI, Vartela V, Ntalianis A, Vretou R, Ikonomidis I, Tselegkidou M, Paraskevaidis I, Markousis-Mavrogenis G, Noutsias M, Rigopoulos A, Kolovou G, Kastritis E. Herz; 2021 Apr 25; 46(Suppl 1):9-14. PubMed ID: 31796976 [Abstract] [Full Text] [Related]
10. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis]. Zhu KB, Cheng ZW, Tian Z, Zhao DC, Liu YT, Lin X, Chen TB, Xie HZ, Zeng Y, Fang LG, Jiang XC, Cui QC, Fang Q. Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct 25; 39(10):915-9. PubMed ID: 22321275 [Abstract] [Full Text] [Related]
11. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis. Pan JA, Kerwin MJ, Salerno M. JACC Cardiovasc Imaging; 2020 Jun 25; 13(6):1299-1310. PubMed ID: 32498919 [Abstract] [Full Text] [Related]
13. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, Klingel K, Kandolf R, Sechtem U. J Am Coll Cardiol; 2008 Mar 11; 51(10):1022-30. PubMed ID: 18325442 [Abstract] [Full Text] [Related]
14. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Yoshida A, Ishibashi-Ueda H, Yamada N, Kanzaki H, Hasegawa T, Takahama H, Amaki M, Asakura M, Kitakaze M. Eur J Heart Fail; 2013 Feb 11; 15(2):166-75. PubMed ID: 23329703 [Abstract] [Full Text] [Related]
15. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, Lachmann HJ, Perlini S, Pontone G, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M. JACC Cardiovasc Imaging; 2020 Jan 11; 13(1 Pt 1):69-80. PubMed ID: 31202744 [Abstract] [Full Text] [Related]
16. Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis. Briasoulis A, Lama N, Rempakos A, Theodorakakou F, Stamatelopoulos K, Dimopoulos MA, Kelekis N, Kastritis E. Curr Probl Cardiol; 2023 Apr 11; 48(4):101573. PubMed ID: 36586704 [Abstract] [Full Text] [Related]